Glaxosmithkline Pharmaceuticals Ltd. (GLAXO): Glaxosmithkline Pharmaceuticals Share Price rises 4.17% today

Published: 28 September 2026 at 12:22:35 PM IST

Glaxosmithkline Pharmaceuticals Share Price moved higher today, with GLAXO ending at Rs 2,934.35 after a 4.17% rise from the previous close of Rs 2,816.85. The move added Rs 117.50 to the stock and came within a session that opened at Rs 2,812, touched a high of Rs 2,986.65 and a low of Rs 2,788.80. Those numbers show a firm upward day, but the supplied data does not identify any company-specific catalyst. For readers following Glaxosmithkline Pharmaceuticals Share Price Today, the important point is the verified market action: a higher close, a wide intraday range and a meaningful move in a large healthcare name. The company’s market capitalisation stood at Rs 47,719.14 crore, which helps place the day’s gain in a clear market-cap context.

That context matters because Glaxosmithkline Pharmaceuticals Share Price did not just rise in isolation; it did so while trading near the upper end of the day’s range. The close was below the session high but comfortably above the opening level and the previous close. In practical terms, that means buyers were able to keep control through much of the session even though the price also visited a lower point during the day. Turnover stood at Rs 2.73 crore, which records the day’s market activity without implying any specific trading pattern beyond the reported figure. The verified facts therefore support a straightforward event summary: GLAXO had a positive day, closed higher, and did so with a notable intraday swing.

Glaxosmithkline Pharmaceuticals Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,934.35
Previous Close	Rs 2,816.85
Today's Move	Rs 117.5 (+4.17%)
Open	Rs 2,812
High	Rs 2,986.65
Low	Rs 2,788.8
Turnover	Rs 2.73 crore
Market Capitalisation	Rs 47,719.14 crore
Market Cap Category	Large Cap

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) rose to Rs 2,934.35 from the previous close of Rs 2,816.85, a move of Rs 117.5 or 4.17%. The stock opened at Rs 2,812, reached a high of Rs 2,986.65, recorded a low of Rs 2,788.8.

The strongest part of this update is the price action itself. Glaxosmithkline Pharmaceuticals Share Price moved from the previous close of Rs 2,816.85 to Rs 2,934.35, and that Rs 117.50 advance translated into a 4.17% rise. The stock opened only slightly below the previous close at Rs 2,812, which means the session started without a sharp gap and then built upward through the day. A high of Rs 2,986.65 shows that the stock briefly traded above the closing level by a meaningful margin, while the low of Rs 2,788.80 shows that the day was not one-way. This combination usually signals active price discovery, not a straight-line move.

For Glaxosmithkline Pharmaceuticals Share Price, the relationship between open, low, high and close is more informative than the percentage change alone. The stock spent the session inside a range of nearly Rs 200, yet finished close to the upper half of that band. That tells readers that the rise was achieved despite some intraday back-and-forth. A higher close after a broad range is often the most useful way to read a session like this, because it separates the final outcome from the day’s temporary swings. In this case, the final price action is clearly positive and the close sits well above the previous session’s reference point.

The turnover of Rs 2.73 crore adds another layer of context. It confirms that the move occurred in an active trading session, but the figure should be read only as market activity data. It does not tell us why the stock moved, and the available information does not support a deeper cause. Still, when combined with the day’s range and closing level, it helps explain why GLAXO share price news attracted attention today. The move was visible, measurable and large enough to matter for a stock of this size.

Another useful takeaway is that the rise was not mirrored by a dramatic opening spike. Since the stock opened at Rs 2,812, the day began close to the prior close and then improved over the course of trading. That pattern can be helpful for readers looking at Glaxosmithkline Pharmaceuticals Share Price as an event-based stock update rather than as a charting exercise. The session facts show a constructive day with a higher settlement, and that is the central market story supplied by the data.

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 47,719.14 crore
P/E Ratio	44.67x
P/B Ratio	18.93x
ROE	48.76%
ROCE	66.79%
EPS	Rs 63.05
Book Value Per Share	Rs 148.77
Dividend Yield	2.02%

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) fundamental metrics show P/E 44.67x, P/B 18.93x, ROE 48.76%, ROCE 66.79%. These figures provide context only and are not a buy or sell signal.

Glaxosmithkline Pharmaceuticals Ltd. has a market capitalisation of Rs 47719.14 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 44.67x, P/B at 18.93x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 48.76% and ROCE of 66.79%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 63.05, book value per share of Rs 148.77, dividend yield of 2.02%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.87x, median ROE of 11.48%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	44.67x
Benchmark Median P/E	32.87x
Benchmark Average P/E	49.63x
Benchmark P/E Range	3.46x to 735.85x
Company P/B Ratio	18.93x
Benchmark Median P/B	2.85x
Company ROE	48.76%
Benchmark Median ROE	11.48%
Company ROCE	66.79%
Benchmark Median ROCE	13.17%
Company Market Capitalisation	Rs 47,719.14 crore
Benchmark Median Market Cap	Rs 732.57 crore

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a P/E ratio of 44.67x, which is above the benchmark median of 32.87x, a difference of +35.9%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a ROE of 48.76%, which is above the benchmark median of 11.48%, a difference of +324.74%. Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a ROCE of 66.79%, which is above the benchmark median of 13.17%, a difference of +407.14%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,44,716.74	36.77	5.14	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,55,115.31	87.22	14.44	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,89,613.38	86.94	21.13	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,19,899.96	26.57	4.45	19.69	21.39
Cipla Ltd.	CIPLA	1,12,875.68	33.49	3.21	11.83	16

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a P/E ratio of 44.67x compared with the displayed peer median of 36.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 48.76% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 66.79% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a market capitalisation of Rs 47,719.14 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Glaxosmithkline Pharmaceuticals

• Glaxosmithkline Pharmaceuticals Share Price rose 4.17% today to Rs 2,934.35 after closing above the previous close of Rs 2,816.85.
• The stock moved between Rs 2,788.80 and Rs 2,986.65 during the session, showing an active intraday range.
• Market capitalisation stood at Rs 47,719.14 crore, giving the move a sizeable market-cap backdrop.
• P/E of 44.67 and P/B of 18.93 place the stock above the industry median on valuation measures.
• ROE of 48.76%, ROCE of 66.79%, EPS of Rs 63.05 and book value of Rs 148.77 are key financial metrics in the stock update.

About Glaxosmithkline Pharmaceuticals

Glaxosmithkline Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company name and industry classification place it within a regulated pharmaceutical business environment, where valuation and return ratios often matter to market participants. In today’s stock news, the company’s market capitalisation of Rs 47,719.14 crore shows a meaningful listed presence within the same industry. The supplied data does not include a segment-wise revenue mix or product breakdown, so the article stays with verified company-level facts. As a result, the most useful company news framing is simple: this is a pharmaceutical business whose share price, financial ratios and peer positioning are now in focus after the same-day rise. Univest is tracking Glaxosmithkline Pharmaceuticals Share Price Today for readers who want the market update in one place.

Track Glaxosmithkline Pharmaceuticals Share Price on Univest

Use Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Use the Glaxosmithkline Pharmaceuticals live share-price page, the Univest top gainers screener and Univest market blogs to review live stock data, top-gainers lists and related market analysis. These pages help readers follow Glaxosmithkline Pharmaceuticals Share Price alongside other active names without relying on a single session alone.

Frequently Asked Questions

Why did Glaxosmithkline Pharmaceuticals Share Price rise today?

Ans. The data confirms a 4.17% same-day rise in Glaxosmithkline Pharmaceuticals Share Price, but it does not establish a company-specific catalyst. The verified facts are the price move, session range, turnover and market capitalisation.

What is Glaxosmithkline Pharmaceuticals Share Price today?

Ans. Glaxosmithkline Pharmaceuticals Share Price today is Rs 2,934.35. It gained Rs 117.50 over the previous close of Rs 2,816.85, and the session high was Rs 2,986.65 while the low was Rs 2,788.80.

What is the market capitalisation of Glaxosmithkline Pharmaceuticals?

Ans. The market capitalisation of Glaxosmithkline Pharmaceuticals stood at Rs 47,719.14 crore. That places the company well above the industry median and average in the supplied same-industry benchmark set. The company operates in the Healthcare sector.

How expensive is Glaxosmithkline Pharmaceuticals based on valuation?

Ans. The stock trades at a P/E of 44.67 and a P/B of 18.93. Those levels are above the industry median in the supplied dataset, while ROE and ROCE are also notably strong, which gives the valuation more context.

What do EPS and book value show for Glaxosmithkline Pharmaceuticals Share Price?

Ans. EPS is Rs 63.05 and book value is Rs 148.77. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share. Both help frame valuation and the stock’s financial profile.